Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Merck
Baxter
Citi
Daiichi Sankyo
Chinese Patent Office
Queensland Health
Healthtrust
McKesson
Teva

Generated: October 20, 2017

DrugPatentWatch Database Preview

DILTIAZEM HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Diltiazem Hydrochloride, and what generic Diltiazem Hydrochloride alternatives are available?

Diltiazem Hydrochloride is a drug marketed by Hospira, Mylan, Valeant Pharms North, Athenex Inc, Sun Pharma Global, Sandoz, Sun Pharm Inds Ltd, Zydus Pharms Usa Inc, West-ward Pharms Int, Biovail, Apotex, Intl Medication, Hikma Farmaceutica, Apothecon, Actavis Labs Fl Inc, Actavis Elizabeth, Nesher Pharms, Teva Pharms, Ivax Sub Teva Pharms, Mylan Labs Ltd, Teva, Par Pharm, Akorn Inc, Chartwell Molecules, and Teva Pharms Usa. and is included in thirty-six NDAs.

The generic ingredient in DILTIAZEM HYDROCHLORIDE is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

Summary for Tradename: DILTIAZEM HYDROCHLORIDE

US Patents:0
Applicants:25
NDAs:36
Suppliers / Packagers: see list44
Bulk Api Vendors: see list50
Clinical Trials: see list2,351
Patent Applications: see list2,157
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DILTIAZEM HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: DILTIAZEM HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL076563-004Sep 12, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
TABLET, EXTENDED RELEASE;ORAL077686-004Mar 15, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-002Jan 28, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL206534-003Aug 8, 2017AB3RXNoNo► Subscribe► Subscribe► Subscribe
Teva
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL074079-002Nov 30, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
INJECTABLE;INJECTION074894-001Aug 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL206641-004Aug 11, 2017AB4RXNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
TABLET;ORAL074093-002Nov 5, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Hikma Farmaceutica
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
INJECTABLE;INJECTION202651-001Aug 9, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-006Sep 14, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DILTIAZEM HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-003Jan 28, 2000► Subscribe► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-001Jan 28, 2000► Subscribe► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-004Jan 28, 2000► Subscribe► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-002Jan 28, 2000► Subscribe► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-002Jan 28, 2000► Subscribe► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-003Jan 28, 2000► Subscribe► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-001Jan 28, 2000► Subscribe► Subscribe
Biovail
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020939-004Jan 28, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
UBS
Covington
Cerilliant
Julphar
Johnson and Johnson
Chinese Patent Office
Chubb
Argus Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot